Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

Human stem cells have diverse sources and potential uses in medicine.

Iodine-deficient diets and antithyroid substances affected rat growth and behavior, but most adapted with positive weight gain.

Environmental factors like smoking, UV exposure, and poor diet contribute to hair loss and graying, and lifestyle changes can help manage it.

The document concludes that protecting skin from the sun, avoiding smoking, and using treatments like Minoxidil and Finasteride can help manage skin and hair aging.

Adrenal disorders often cause high blood pressure in young people.

Oxidized LDL reduces cell growth but affects stem cell differentiation less negatively than cytokine-induced inflammation.

Histone modification is key in treating chronic inflammatory skin diseases.

Exosomes from special stem cells help treat ulcerative colitis by reducing inflammation and stress.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

Skin lesions in Carney complex are likely caused by a specific group of skin cells that promote pigment production due to a genetic mutation.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

Follicle Stimulating Hormone is important for fertility.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

EpiLife® media and younger donor age improve artificial skin model quality.

FDG PET/CT can improve cancer treatment plans in dogs.

The document covers various dermatological treatments and conditions.

A 19-year-old with MRKHS developed complete hair loss, and treatment options were discussed.

Severe sarcoidosis often requires long-term systemic corticosteroids and multidisciplinary care, with most patients improving but some experiencing persistent symptoms or complications.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

Hair test results can be misleading due to external contamination, so they shouldn't be used alone to assess long-term drug use.

Alopecia X in dogs is a cosmetic issue, not a hormonal disorder, and harmful treatments should be avoided.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Female pattern hair loss affects crown, increases with age, and has limited treatments.

PRP injections may be an effective treatment for severe hair loss.

The document's conclusion cannot be provided because the document is not accessible or understandable.